Treatment Patterns, Health Care Resource Utilization, and Costs in Patients with Relapsed/refractory Hodgkin Lymphoma Treated with Brentuximab Vedotin.
Leukemia & lymphoma/Leukemia and lymphoma（2018）
关键词
Brentuximab vedotin,relapsed,refractory Hodgkin lymphoma,health care resource utilization,cost analysis,treatment patterns
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要